Review





Similar Products

97
Sartorius AG iggs
A. Cell phenotypic selections for <t>IgGs</t> targeting suppressive macrophages were performed on human macrophages (unstimulated M0, LPS stimulated, IFN-γ + LPS stimulated (M1), or IL-4 + LPS stimulated (M2)) using a synthetic scFv library (REF library). After two rounds of selections, the scFv from the eluted phage were converted into huIgG1TM. B. A high-throughput binding screening was performed on each of the induced macrophage populations by mirrorball TM and high-content imaging. Two functional screens measured the expression of CXCL10 and CD80 genes in LPS-stimulated macrophages treated with mAbs for 48h. C. Expression of CXCL10 or CD80 normalized to GAPDH housekeeper gene was quantified in 6 human donors. D. Three functional hits demonstrating binding to <t>CD36-transfected</t> 293FT cells as assessed by mirrorball TM . E. Log-normalized CD36 expression from single-cell RNAseq analysis of human NSCLC (n = 5) and (F) melanoma patients (n = 25) . Whiskers represent the min-max values. G. CD36 expression on tumor- vs spleen-infiltrated CD11b+ myeloid cells in MC38 (n = 6) and B16F10 (n = 8) subcutaneous tumor-bearing mice, as assessed by flow cytometry. Tumors were analysed 14 days post-implantation of tumor cells and expression was compared to isotype control antibody (dashed lines). P-value represents an unpaired T-test result.
Iggs, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Octet+Anti-Human+Fc+Capture+(AHC)+Biosensors/pmc13759077-87-6-22
Average 97 stars, based on 1 article reviews
iggs - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Jackson Immuno biotin conjugated goat antihuman igg antibody
A. Cell phenotypic selections for <t>IgGs</t> targeting suppressive macrophages were performed on human macrophages (unstimulated M0, LPS stimulated, IFN-γ + LPS stimulated (M1), or IL-4 + LPS stimulated (M2)) using a synthetic scFv library (REF library). After two rounds of selections, the scFv from the eluted phage were converted into huIgG1TM. B. A high-throughput binding screening was performed on each of the induced macrophage populations by mirrorball TM and high-content imaging. Two functional screens measured the expression of CXCL10 and CD80 genes in LPS-stimulated macrophages treated with mAbs for 48h. C. Expression of CXCL10 or CD80 normalized to GAPDH housekeeper gene was quantified in 6 human donors. D. Three functional hits demonstrating binding to <t>CD36-transfected</t> 293FT cells as assessed by mirrorball TM . E. Log-normalized CD36 expression from single-cell RNAseq analysis of human NSCLC (n = 5) and (F) melanoma patients (n = 25) . Whiskers represent the min-max values. G. CD36 expression on tumor- vs spleen-infiltrated CD11b+ myeloid cells in MC38 (n = 6) and B16F10 (n = 8) subcutaneous tumor-bearing mice, as assessed by flow cytometry. Tumors were analysed 14 days post-implantation of tumor cells and expression was compared to isotype control antibody (dashed lines). P-value represents an unpaired T-test result.
Biotin Conjugated Goat Antihuman Igg Antibody, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Goat+Anti-Human+IgG/pmc13768716-56-12-20
Average 96 stars, based on 1 article reviews
biotin conjugated goat antihuman igg antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
R&D Systems nanog
( A and B ) qRT-PCR for indicated genes before (control) or after DOX-induced expression of dCas9-KRAB (CRISPRi) (A) or dCas9-SunTag-VP64 (CRISPRa) (B) and gRNAs targeting primed enhancers or active enhancers ( SFRP2 , EEIG2 ) in hiPSCs. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( C and D ) Top: Gel electrophoresis analysis of PCR amplification of genomic DNA using primers flanking the APLN (C), PDLIM1 [(D), left], or SOX4 [(D), right] enhancer in wild-type (WT) and knockout (KO) clones. Bottom: qRT-PCR for target gene expression in wild-type and enhancer knockout clones. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( E ) Live-cell imaging of hiPSCs without (control) or with DOX/TMP (CRISPRi) to induce the expression of dCas9-KRAB (GFP-positive cells) with three gRNAs targeting the primed SLC13A4 enhancer. ( F ) Proportion of remaining cells (in %) during live-cell imaging as described in (E). ( G ) Immunofluorescence images for <t>SOX2</t> and <t>NANOG</t> of hiPSCs before (control) or after addition of DOX/TMP (days 1 to 4) for dCas9-KRAB expression (GFP-positive cells) with three gRNAs. DNA was counterstained. ( H ) Quantification of fluorescence intensities of images shown in (G). Two-sided Mann-Whitney U test with Benjamini-Hochberg correction for multiple testing. *** P < 0.001. ( I ) The heatmap shows relative expression levels of genes +/−1 Mb of the SLC13A4 locus on the basis of RNA-seq data for hiPSCs after the addition of DOX/TMP for 1 day [day 1 (D1)] or 2 days [day 2 (D2)] to induce dCas9-KRAB with constitutive expression of gRNAs targeting the enhancer of SLC13A4 . ( J ) The volcano plot shows differentially expressed genes of RNA-seq data at D1, as described in (I). NS, not significant; FC, fold change. ( K ) Coverage tracks showing the SLC13A4 enhancer region in hiPSCs and H3K9me3 and CTCF CUT&Tag tracks showing the same SLC13A4 enhancer genomic region in control and enhancer CRISPRi conditions.
Nanog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Human+Nanog+Antibody/pmc13763835-392-17-18
Average 94 stars, based on 1 article reviews
nanog - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Jackson Immuno fitc conjugated f ab 2 goat anti human igg
( A and B ) qRT-PCR for indicated genes before (control) or after DOX-induced expression of dCas9-KRAB (CRISPRi) (A) or dCas9-SunTag-VP64 (CRISPRa) (B) and gRNAs targeting primed enhancers or active enhancers ( SFRP2 , EEIG2 ) in hiPSCs. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( C and D ) Top: Gel electrophoresis analysis of PCR amplification of genomic DNA using primers flanking the APLN (C), PDLIM1 [(D), left], or SOX4 [(D), right] enhancer in wild-type (WT) and knockout (KO) clones. Bottom: qRT-PCR for target gene expression in wild-type and enhancer knockout clones. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( E ) Live-cell imaging of hiPSCs without (control) or with DOX/TMP (CRISPRi) to induce the expression of dCas9-KRAB (GFP-positive cells) with three gRNAs targeting the primed SLC13A4 enhancer. ( F ) Proportion of remaining cells (in %) during live-cell imaging as described in (E). ( G ) Immunofluorescence images for <t>SOX2</t> and <t>NANOG</t> of hiPSCs before (control) or after addition of DOX/TMP (days 1 to 4) for dCas9-KRAB expression (GFP-positive cells) with three gRNAs. DNA was counterstained. ( H ) Quantification of fluorescence intensities of images shown in (G). Two-sided Mann-Whitney U test with Benjamini-Hochberg correction for multiple testing. *** P < 0.001. ( I ) The heatmap shows relative expression levels of genes +/−1 Mb of the SLC13A4 locus on the basis of RNA-seq data for hiPSCs after the addition of DOX/TMP for 1 day [day 1 (D1)] or 2 days [day 2 (D2)] to induce dCas9-KRAB with constitutive expression of gRNAs targeting the enhancer of SLC13A4 . ( J ) The volcano plot shows differentially expressed genes of RNA-seq data at D1, as described in (I). NS, not significant; FC, fold change. ( K ) Coverage tracks showing the SLC13A4 enhancer region in hiPSCs and H3K9me3 and CTCF CUT&Tag tracks showing the same SLC13A4 enhancer genomic region in control and enhancer CRISPRi conditions.
Fitc Conjugated F Ab 2 Goat Anti Human Igg, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Goat+Anti-Human+IgG/pmc13768760-122-14-20
Average 96 stars, based on 1 article reviews
fitc conjugated f ab 2 goat anti human igg - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
R&D Systems trem2 antibody
<t>TREM2+</t> macrophages are markedly enriched in endometriosis. (A) UMAP plot of macrophage subclusters shared across PF and tissue samples. (B) Heatmap of differentially expressed genes across the five macrophage subpopulations. (C) Violin plot of TREM2 expression across macrophage subsets. (D) RNA velocity streamlines projected onto the UMAP embedding. (E, F) Stacked bar charts of macrophage subset composition in PF (E) and tissue (F) samples from individual patients. (G) KEGG pathway enrichment of the top 100 marker genes of TREM2 + macrophages, grouped by pathway category. (H) Representative flow cytometry image and quantification of TREM2 MFI in PF macrophages (Endo, n = 18; Ctrl, n = 10). (I) Representative flow cytometry image and quantification of TREM2 MFI in tissue macrophages (Endo, n = 25; Ctrl, n = 14). (J) Western blot quantification of TREM2 protein levels in PF macrophages ( n = 8 per group). (K) Representative immunofluorescence images of ectopic lesions and control cysts. CD68 (green), TREM2 (red), DAPI (blue). Boxed regions are magnified on the right. Scale bars: 150 µm (left four columns) and 41.6 µm (magnified panels). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (H, I): Unpaired two‐tailed Mann‐Whitney U test. (J): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01.
Trem2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Human%2FMouse+TREM2+Antibody/pmc13755765-246-18-21
Average 94 stars, based on 1 article reviews
trem2 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Sartorius AG octet anti human igg fc capture ahc biosensors
A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on <t>anti-human</t> Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.
Octet Anti Human Igg Fc Capture Ahc Biosensors, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Octet/pmc13759077-87-14-22
Average 99 stars, based on 1 article reviews
octet anti human igg fc capture ahc biosensors - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Jackson Immuno fragment goat anti human igg
A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on <t>anti-human</t> Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.
Fragment Goat Anti Human Igg, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Goat+Anti-Human+IgG/pmc13759077-69-8-15
Average 96 stars, based on 1 article reviews
fragment goat anti human igg - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
R&D Systems polyclonal goat anti human cd4 primary antibody
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Polyclonal Goat Anti Human Cd4 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Human+CD4+Antibody/pmc13759070-94-10-18
Average 94 stars, based on 1 article reviews
polyclonal goat anti human cd4 primary antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
R&D Systems sheep polyclonal anti trypsin
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Sheep Polyclonal Anti Trypsin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Human+Trypsin+Pan+Specific+(PRSS1%2F2%2F3)+Antibody/pm42962661-832-93-96
Average 92 stars, based on 1 article reviews
sheep polyclonal anti trypsin - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
R&D Systems goat anti cate
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Goat Anti Cate, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human/Human+Cathepsin+E+Antibody/pmc13755073-106-8-11
Average 93 stars, based on 1 article reviews
goat anti cate - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


A. Cell phenotypic selections for IgGs targeting suppressive macrophages were performed on human macrophages (unstimulated M0, LPS stimulated, IFN-γ + LPS stimulated (M1), or IL-4 + LPS stimulated (M2)) using a synthetic scFv library (REF library). After two rounds of selections, the scFv from the eluted phage were converted into huIgG1TM. B. A high-throughput binding screening was performed on each of the induced macrophage populations by mirrorball TM and high-content imaging. Two functional screens measured the expression of CXCL10 and CD80 genes in LPS-stimulated macrophages treated with mAbs for 48h. C. Expression of CXCL10 or CD80 normalized to GAPDH housekeeper gene was quantified in 6 human donors. D. Three functional hits demonstrating binding to CD36-transfected 293FT cells as assessed by mirrorball TM . E. Log-normalized CD36 expression from single-cell RNAseq analysis of human NSCLC (n = 5) and (F) melanoma patients (n = 25) . Whiskers represent the min-max values. G. CD36 expression on tumor- vs spleen-infiltrated CD11b+ myeloid cells in MC38 (n = 6) and B16F10 (n = 8) subcutaneous tumor-bearing mice, as assessed by flow cytometry. Tumors were analysed 14 days post-implantation of tumor cells and expression was compared to isotype control antibody (dashed lines). P-value represents an unpaired T-test result.

Journal: PLOS One

Article Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

doi: 10.1371/journal.pone.0362100

Figure Lengend Snippet: A. Cell phenotypic selections for IgGs targeting suppressive macrophages were performed on human macrophages (unstimulated M0, LPS stimulated, IFN-γ + LPS stimulated (M1), or IL-4 + LPS stimulated (M2)) using a synthetic scFv library (REF library). After two rounds of selections, the scFv from the eluted phage were converted into huIgG1TM. B. A high-throughput binding screening was performed on each of the induced macrophage populations by mirrorball TM and high-content imaging. Two functional screens measured the expression of CXCL10 and CD80 genes in LPS-stimulated macrophages treated with mAbs for 48h. C. Expression of CXCL10 or CD80 normalized to GAPDH housekeeper gene was quantified in 6 human donors. D. Three functional hits demonstrating binding to CD36-transfected 293FT cells as assessed by mirrorball TM . E. Log-normalized CD36 expression from single-cell RNAseq analysis of human NSCLC (n = 5) and (F) melanoma patients (n = 25) . Whiskers represent the min-max values. G. CD36 expression on tumor- vs spleen-infiltrated CD11b+ myeloid cells in MC38 (n = 6) and B16F10 (n = 8) subcutaneous tumor-bearing mice, as assessed by flow cytometry. Tumors were analysed 14 days post-implantation of tumor cells and expression was compared to isotype control antibody (dashed lines). P-value represents an unpaired T-test result.

Article Snippet: Assays to test the affinity of IgGs for human CD36 were set up using OCTET anti-human IgG Fc capture (AHC) biosensors (18–5060; Sartorius) according to the manufacturer’s instructions.

Techniques: Sample Throughput, Binding Assay, Screening, High Content Screening, Functional Assay, Expressing, Transfection, Single Cell, RNA Sequencing, Analysis, Flow Cytometry, Control, Phage Display

Tool  anti-CD36   IgGs.

Journal: PLOS One

Article Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

doi: 10.1371/journal.pone.0362100

Figure Lengend Snippet: Tool anti-CD36 IgGs.

Article Snippet: Assays to test the affinity of IgGs for human CD36 were set up using OCTET anti-human IgG Fc capture (AHC) biosensors (18–5060; Sartorius) according to the manufacturer’s instructions.

Techniques:

A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Journal: PLOS One

Article Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

doi: 10.1371/journal.pone.0362100

Figure Lengend Snippet: A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Article Snippet: Assays to test the affinity of IgGs for human CD36 were set up using OCTET anti-human IgG Fc capture (AHC) biosensors (18–5060; Sartorius) according to the manufacturer’s instructions.

Techniques: Selection, Clone Assay, Incubation, Recombinant, Binding Assay, High Content Screening, Fluorescence, Inhibition, Binding Curves

( A and B ) qRT-PCR for indicated genes before (control) or after DOX-induced expression of dCas9-KRAB (CRISPRi) (A) or dCas9-SunTag-VP64 (CRISPRa) (B) and gRNAs targeting primed enhancers or active enhancers ( SFRP2 , EEIG2 ) in hiPSCs. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( C and D ) Top: Gel electrophoresis analysis of PCR amplification of genomic DNA using primers flanking the APLN (C), PDLIM1 [(D), left], or SOX4 [(D), right] enhancer in wild-type (WT) and knockout (KO) clones. Bottom: qRT-PCR for target gene expression in wild-type and enhancer knockout clones. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( E ) Live-cell imaging of hiPSCs without (control) or with DOX/TMP (CRISPRi) to induce the expression of dCas9-KRAB (GFP-positive cells) with three gRNAs targeting the primed SLC13A4 enhancer. ( F ) Proportion of remaining cells (in %) during live-cell imaging as described in (E). ( G ) Immunofluorescence images for SOX2 and NANOG of hiPSCs before (control) or after addition of DOX/TMP (days 1 to 4) for dCas9-KRAB expression (GFP-positive cells) with three gRNAs. DNA was counterstained. ( H ) Quantification of fluorescence intensities of images shown in (G). Two-sided Mann-Whitney U test with Benjamini-Hochberg correction for multiple testing. *** P < 0.001. ( I ) The heatmap shows relative expression levels of genes +/−1 Mb of the SLC13A4 locus on the basis of RNA-seq data for hiPSCs after the addition of DOX/TMP for 1 day [day 1 (D1)] or 2 days [day 2 (D2)] to induce dCas9-KRAB with constitutive expression of gRNAs targeting the enhancer of SLC13A4 . ( J ) The volcano plot shows differentially expressed genes of RNA-seq data at D1, as described in (I). NS, not significant; FC, fold change. ( K ) Coverage tracks showing the SLC13A4 enhancer region in hiPSCs and H3K9me3 and CTCF CUT&Tag tracks showing the same SLC13A4 enhancer genomic region in control and enhancer CRISPRi conditions.

Journal: Science Advances

Article Title: Noncanonical enhancers control gene expression and cell fate in human pluripotent stem cells

doi: 10.1126/sciadv.adz3328

Figure Lengend Snippet: ( A and B ) qRT-PCR for indicated genes before (control) or after DOX-induced expression of dCas9-KRAB (CRISPRi) (A) or dCas9-SunTag-VP64 (CRISPRa) (B) and gRNAs targeting primed enhancers or active enhancers ( SFRP2 , EEIG2 ) in hiPSCs. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( C and D ) Top: Gel electrophoresis analysis of PCR amplification of genomic DNA using primers flanking the APLN (C), PDLIM1 [(D), left], or SOX4 [(D), right] enhancer in wild-type (WT) and knockout (KO) clones. Bottom: qRT-PCR for target gene expression in wild-type and enhancer knockout clones. 2 −ΔΔCt ± SD; normalization using GAPDH . Two-tailed paired Student’s t test: * P < 0.05; ** P < 0.01; *** P < 0.001. ( E ) Live-cell imaging of hiPSCs without (control) or with DOX/TMP (CRISPRi) to induce the expression of dCas9-KRAB (GFP-positive cells) with three gRNAs targeting the primed SLC13A4 enhancer. ( F ) Proportion of remaining cells (in %) during live-cell imaging as described in (E). ( G ) Immunofluorescence images for SOX2 and NANOG of hiPSCs before (control) or after addition of DOX/TMP (days 1 to 4) for dCas9-KRAB expression (GFP-positive cells) with three gRNAs. DNA was counterstained. ( H ) Quantification of fluorescence intensities of images shown in (G). Two-sided Mann-Whitney U test with Benjamini-Hochberg correction for multiple testing. *** P < 0.001. ( I ) The heatmap shows relative expression levels of genes +/−1 Mb of the SLC13A4 locus on the basis of RNA-seq data for hiPSCs after the addition of DOX/TMP for 1 day [day 1 (D1)] or 2 days [day 2 (D2)] to induce dCas9-KRAB with constitutive expression of gRNAs targeting the enhancer of SLC13A4 . ( J ) The volcano plot shows differentially expressed genes of RNA-seq data at D1, as described in (I). NS, not significant; FC, fold change. ( K ) Coverage tracks showing the SLC13A4 enhancer region in hiPSCs and H3K9me3 and CTCF CUT&Tag tracks showing the same SLC13A4 enhancer genomic region in control and enhancer CRISPRi conditions.

Article Snippet: The cells were incubated overnight at 4°C with primary antibodies against SOX2 (Santa Cruz, sc-365823, 1:500) and NANOG (R&D, AF1997, 1:100) in PB.

Techniques: Quantitative RT-PCR, Control, Expressing, Two Tailed Test, Gel Electrophoresis, Analysis, Amplification, Knock-Out, Clone Assay, Targeted Gene Expression, Live Cell Imaging, Immunofluorescence, Fluorescence, MANN-WHITNEY, RNA Sequencing, CUT&Tag

TREM2+ macrophages are markedly enriched in endometriosis. (A) UMAP plot of macrophage subclusters shared across PF and tissue samples. (B) Heatmap of differentially expressed genes across the five macrophage subpopulations. (C) Violin plot of TREM2 expression across macrophage subsets. (D) RNA velocity streamlines projected onto the UMAP embedding. (E, F) Stacked bar charts of macrophage subset composition in PF (E) and tissue (F) samples from individual patients. (G) KEGG pathway enrichment of the top 100 marker genes of TREM2 + macrophages, grouped by pathway category. (H) Representative flow cytometry image and quantification of TREM2 MFI in PF macrophages (Endo, n = 18; Ctrl, n = 10). (I) Representative flow cytometry image and quantification of TREM2 MFI in tissue macrophages (Endo, n = 25; Ctrl, n = 14). (J) Western blot quantification of TREM2 protein levels in PF macrophages ( n = 8 per group). (K) Representative immunofluorescence images of ectopic lesions and control cysts. CD68 (green), TREM2 (red), DAPI (blue). Boxed regions are magnified on the right. Scale bars: 150 µm (left four columns) and 41.6 µm (magnified panels). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (H, I): Unpaired two‐tailed Mann‐Whitney U test. (J): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01.

Journal: Advanced Science

Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

doi: 10.1002/advs.78385

Figure Lengend Snippet: TREM2+ macrophages are markedly enriched in endometriosis. (A) UMAP plot of macrophage subclusters shared across PF and tissue samples. (B) Heatmap of differentially expressed genes across the five macrophage subpopulations. (C) Violin plot of TREM2 expression across macrophage subsets. (D) RNA velocity streamlines projected onto the UMAP embedding. (E, F) Stacked bar charts of macrophage subset composition in PF (E) and tissue (F) samples from individual patients. (G) KEGG pathway enrichment of the top 100 marker genes of TREM2 + macrophages, grouped by pathway category. (H) Representative flow cytometry image and quantification of TREM2 MFI in PF macrophages (Endo, n = 18; Ctrl, n = 10). (I) Representative flow cytometry image and quantification of TREM2 MFI in tissue macrophages (Endo, n = 25; Ctrl, n = 14). (J) Western blot quantification of TREM2 protein levels in PF macrophages ( n = 8 per group). (K) Representative immunofluorescence images of ectopic lesions and control cysts. CD68 (green), TREM2 (red), DAPI (blue). Boxed regions are magnified on the right. Scale bars: 150 µm (left four columns) and 41.6 µm (magnified panels). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (H, I): Unpaired two‐tailed Mann‐Whitney U test. (J): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01.

Article Snippet: Slides were incubated at 4°C with primary antibodies overnight, including CD68 Polyclonal antibody (25747‐1‐AP, Proteintech, China, 1:200) and TREM2 antibody (MAB17291, R&D Systems, USA, 1:200).

Techniques: Tissue, Expressing, Marker, Flow Cytometry, Western Blot, Immunofluorescence, Control, Two Tailed Test, MANN-WHITNEY

TREM2 + macrophages regulate CD8 + T cell function through SPP1‐CD44 mediated communication. (A) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in PF. (B) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in tissues. (C) Representative CFSE image and quantification of proliferation of CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 8 per group). (D) Relative protein expression of PD‐1 in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (E) Relative Pdcd1 mRNA expression in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (F) Dot plot of statistically significant ligand‐ receptor interactions between TREM2 + macrophages and CD8 + T cells or NK cells in tissues. (G) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (I) Heatmaps of BAG signaling pathway activity in cell–cell communication networks from Ctrl PF and Endo PF. (J) Chord diagrams illustrating BAG signaling pathway interactions among immune cell subsets in Ctrl PF and Endo PF. (K) Western blot analysis and quantification of BAG3 expression in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (L) Representative western blots and quantification of autophagy‐related proteins in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (C): Unpaired two‐tailed Mann‐Whitney U test; (D, E, L): Unpaired two‐tailed Student's t ‐test; (G, H, K): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Advanced Science

Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

doi: 10.1002/advs.78385

Figure Lengend Snippet: TREM2 + macrophages regulate CD8 + T cell function through SPP1‐CD44 mediated communication. (A) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in PF. (B) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in tissues. (C) Representative CFSE image and quantification of proliferation of CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 8 per group). (D) Relative protein expression of PD‐1 in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (E) Relative Pdcd1 mRNA expression in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (F) Dot plot of statistically significant ligand‐ receptor interactions between TREM2 + macrophages and CD8 + T cells or NK cells in tissues. (G) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (I) Heatmaps of BAG signaling pathway activity in cell–cell communication networks from Ctrl PF and Endo PF. (J) Chord diagrams illustrating BAG signaling pathway interactions among immune cell subsets in Ctrl PF and Endo PF. (K) Western blot analysis and quantification of BAG3 expression in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (L) Representative western blots and quantification of autophagy‐related proteins in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (C): Unpaired two‐tailed Mann‐Whitney U test; (D, E, L): Unpaired two‐tailed Student's t ‐test; (G, H, K): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Slides were incubated at 4°C with primary antibodies overnight, including CD68 Polyclonal antibody (25747‐1‐AP, Proteintech, China, 1:200) and TREM2 antibody (MAB17291, R&D Systems, USA, 1:200).

Techniques: Cell Function Assay, Immune Cell, Cell Culture, Expressing, Co-culture Assay, Flow Cytometry, Blocking Assay, Activity Assay, Western Blot, Analysis, Two Tailed Test, MANN-WHITNEY

BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

Journal: Advanced Science

Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

doi: 10.1002/advs.78385

Figure Lengend Snippet: BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

Article Snippet: Slides were incubated at 4°C with primary antibodies overnight, including CD68 Polyclonal antibody (25747‐1‐AP, Proteintech, China, 1:200) and TREM2 antibody (MAB17291, R&D Systems, USA, 1:200).

Techniques: Western Blot, Expressing, Flow Cytometry, Cell Culture, Membrane, Fluorescence, Co-culture Assay, Transfection, Knockdown, Two Tailed Test

TREM2 deficiency enhances CD8 + T and NK cell cytotoxicity and inhibits endometriotic lesion growth. (A) Representative endometriotic lesion images in WT, TREM2‐KO, TREM2‐KO + anti‐CD8, TREM2‐KO + anti‐NK1.1, and TREM2‐KO + anti‐CD8 + anti‐NK1.1 mice. (B) Quantification of lesion weight across the five groups ( n = 5 per group). (C) Representative flow cytometry gating strategy for analyzing functional markers of CD8 + T cells and NK cells in PF and ectopic lesions from WT and TREM2‐KO mice. (D) Quantification of functional markers by flow cytometry in WT and TREM2‐KO mice ( n = 7 per group). (E) Representative endometriotic lesion image and quantification of lesion weight between isotype and anti‐TREM2 group ( n = 6 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (B): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (D, E): Unpaired two‐tailed Student's t ‐test. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns, not significant.

Journal: Advanced Science

Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

doi: 10.1002/advs.78385

Figure Lengend Snippet: TREM2 deficiency enhances CD8 + T and NK cell cytotoxicity and inhibits endometriotic lesion growth. (A) Representative endometriotic lesion images in WT, TREM2‐KO, TREM2‐KO + anti‐CD8, TREM2‐KO + anti‐NK1.1, and TREM2‐KO + anti‐CD8 + anti‐NK1.1 mice. (B) Quantification of lesion weight across the five groups ( n = 5 per group). (C) Representative flow cytometry gating strategy for analyzing functional markers of CD8 + T cells and NK cells in PF and ectopic lesions from WT and TREM2‐KO mice. (D) Quantification of functional markers by flow cytometry in WT and TREM2‐KO mice ( n = 7 per group). (E) Representative endometriotic lesion image and quantification of lesion weight between isotype and anti‐TREM2 group ( n = 6 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (B): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (D, E): Unpaired two‐tailed Student's t ‐test. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns, not significant.

Article Snippet: Slides were incubated at 4°C with primary antibodies overnight, including CD68 Polyclonal antibody (25747‐1‐AP, Proteintech, China, 1:200) and TREM2 antibody (MAB17291, R&D Systems, USA, 1:200).

Techniques: Flow Cytometry, Functional Assay, Two Tailed Test

A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Journal: PLOS One

Article Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

doi: 10.1371/journal.pone.0362100

Figure Lengend Snippet: A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Article Snippet: Assays to test the affinity of IgGs for human CD36 were set up using OCTET anti-human IgG Fc capture (AHC) biosensors (18–5060; Sartorius) according to the manufacturer’s instructions.

Techniques: Selection, Clone Assay, Incubation, Recombinant, Binding Assay, High Content Screening, Fluorescence, Inhibition, Binding Curves

A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Journal: PLOS One

Article Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

doi: 10.1371/journal.pone.0362100

Figure Lengend Snippet: A. anti-CD36 mAbs from cell selection hits or commercial clones, or isotype controls were captured on anti-human Fc BLI sensors, then sequentially incubated with increasing concentrations of recombinant human or mouse CD36 extracellular domain with a C-terminal avi-tag. Mouse and human CD36 binding affinities and k on / k off rates are shown. In B, profiles are shown for antibodies and subsequently oxLDL binding to immobilized biotinylated human CD36 protein on streptavidin biosensors. BLI sensors loaded with hCD36 were incubated with anti-CD36 antibodies or matched isotype controls, followed by incubation in oxLDL, to test for antibody-mediated competition for the oxLDL binding site on CD36. C. Magnification of oxLDL association/dissociation steps, vertically aligned at the start of oxLDL binding. Immobilized CD36 pre-treated with non-binding mAbs showed binding of soluble oxLDL, whereas CD36 pre-coated with anti-CD36 mAbs blocked oxLDL binding. D. Infographic showing high-content imaging oxLDL cellular uptake assay. CHO-K1 parental cells and cells overexpressing full-length CD36 were incubated for 4 h with 50 μg/mL DiI-oxLDL in the presence of isotype and anti-CD36 IgGs. Representative overexposed 10X-magnified fluorescence images of DiI-oxLDL-incubated cells shows pre-treated or untreated with Macro0579 (50 nM). E-G. Total spot area of DiI-oxLDL in response to titrated IgG1 concentrations in parental CHO (E), mouse-CD36 (F) and (G) human-CD36 overexpressing CHO cells. Minimal uptake is observed in parental CHO cells whereas robust inhibition of uptake is seen in CD36-overexpressing cells blocked with increasing doses of anti-CD36 IgG1.

Article Snippet: As secondary Ab, Alexa Fluor 647-conjugated AffiniPure F(ab’)2 fragment goat anti-human IgG, Fcγ Fragment specific (Jackson ImmunoResearch Lab Inc.) was used at 1 μg/mL 1/1000 in assay buffer (0.1% BSA (Sigma) in Hank’s Balanced Salt Solution (HBSS; Sigma).

Techniques: Selection, Clone Assay, Incubation, Recombinant, Binding Assay, High Content Screening, Fluorescence, Inhibition, Binding Curves

(A) HOS cells expressing CCR5 (R5 tropic virus; left), HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. CD4-positive cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while T-cell lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: (A) HOS cells expressing CCR5 (R5 tropic virus; left), HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. CD4-positive cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while T-cell lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Expressing, Virus, Infection, Luciferase, Activity Assay, Control, Western Blot, Blocking Assay, Quantitative RT-PCR

Summary of flow cytometry results for the cell-surface expression of  CD4,  CXCR4 and CCR5 on HOS cells (see <xref ref-type= S2 Fig for flow data)." width="100%" height="100%">

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: Summary of flow cytometry results for the cell-surface expression of CD4, CXCR4 and CCR5 on HOS cells (see S2 Fig for flow data).

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Flow Cytometry, Expressing

Cells were infected with the HIV-1 GFP reporter virus and imaged at 72 hours post-infection using fluorescence microscopy. A substantially higher population of GFP-positive cells was observed in the CD4-positive group compared to the CD4-negative cells. Notably, GFP expression in CD4-negative cells confirms viral integration, demonstrating that these cells support HIV-1 infection. Experiments were repeated 3 times; a representative result is shown.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: Cells were infected with the HIV-1 GFP reporter virus and imaged at 72 hours post-infection using fluorescence microscopy. A substantially higher population of GFP-positive cells was observed in the CD4-positive group compared to the CD4-negative cells. Notably, GFP expression in CD4-negative cells confirms viral integration, demonstrating that these cells support HIV-1 infection. Experiments were repeated 3 times; a representative result is shown.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Infection, Virus, Fluorescence, Microscopy, Expressing

HOS cells were infected with luciferase reporter viruses in the presence of coreceptor antagonists or with non-enveloped virus. (A)Top: Infection of HOS-CCR5 + cells with maraviroc and raltegravir & Bottom: Infection of HOS-CXCR4 + cells with Plerixafor (AMD3100) and raltegravir. Cells were pretreated for 1 hour with either 1 µM raltegravir, 1 µM maraviroc, 1 µM AMD3100 or with vehicle control (0.1% DMSO) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle controls. Vehicle control yielded readouts of 3.2 × 10 7 RLU (CD4-positive) and 3.7 × 10 4 RLU (CD4-negative) in Top, and 4.2 × 10 6 RLU (CD4-positive) and 9.0 × 10 4 RLU (CD4-negative) in Bottom. In CD4-positive cells, raltegravir, maraviroc, and AMD3100 all produced significant inhibition. Raltegravir achieved near-complete inhibition in CD4-negative cells, and AMD3100 reduced infection in CD4-negative X4 cells by ~50%. Data are representative of one biological replicate; each condition was tested in 3–6 technical replicates, with the number of independent experiments as follows: Raltegravir, n = 4; AMD3100, n = 1; Maraviroc, n = 2. (B) HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells (Top) and HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells (Bottom). Cells were infected with HIV-1 luciferase reporter virus containing HIV-1 envelope (Env) or lacking envelope (Non-Env). 48 hours post infection RLU was measured. “No virus” wells (cells plus reagents, no virus) served as negative controls. Data are presented as luciferase activity. Representative data from one of two independent biological experiments, each performed with 3–6 technical replicates per condition. Significantly higher infection was observed in CD4-positive cells exposed to envelope-containing virus compared to envelope-deficient controls. In CD4-negative R5 cells (Top right), there was no significant difference in the level of infection with or without the envelope added. CD4-negative X4 cells (Bottom right) indicated a significantly higher level of infection with the addition of envelope demonstrating that HIV-1 infection in these CD4-negative cells is envelope-dependent.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: HOS cells were infected with luciferase reporter viruses in the presence of coreceptor antagonists or with non-enveloped virus. (A)Top: Infection of HOS-CCR5 + cells with maraviroc and raltegravir & Bottom: Infection of HOS-CXCR4 + cells with Plerixafor (AMD3100) and raltegravir. Cells were pretreated for 1 hour with either 1 µM raltegravir, 1 µM maraviroc, 1 µM AMD3100 or with vehicle control (0.1% DMSO) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle controls. Vehicle control yielded readouts of 3.2 × 10 7 RLU (CD4-positive) and 3.7 × 10 4 RLU (CD4-negative) in Top, and 4.2 × 10 6 RLU (CD4-positive) and 9.0 × 10 4 RLU (CD4-negative) in Bottom. In CD4-positive cells, raltegravir, maraviroc, and AMD3100 all produced significant inhibition. Raltegravir achieved near-complete inhibition in CD4-negative cells, and AMD3100 reduced infection in CD4-negative X4 cells by ~50%. Data are representative of one biological replicate; each condition was tested in 3–6 technical replicates, with the number of independent experiments as follows: Raltegravir, n = 4; AMD3100, n = 1; Maraviroc, n = 2. (B) HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells (Top) and HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells (Bottom). Cells were infected with HIV-1 luciferase reporter virus containing HIV-1 envelope (Env) or lacking envelope (Non-Env). 48 hours post infection RLU was measured. “No virus” wells (cells plus reagents, no virus) served as negative controls. Data are presented as luciferase activity. Representative data from one of two independent biological experiments, each performed with 3–6 technical replicates per condition. Significantly higher infection was observed in CD4-positive cells exposed to envelope-containing virus compared to envelope-deficient controls. In CD4-negative R5 cells (Top right), there was no significant difference in the level of infection with or without the envelope added. CD4-negative X4 cells (Bottom right) indicated a significantly higher level of infection with the addition of envelope demonstrating that HIV-1 infection in these CD4-negative cells is envelope-dependent.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Infection, Luciferase, Virus, Control, Produced, Inhibition, Activity Assay

(A) Schematic and gating strategy for the HI.fate dual‑fluorescent reporter system. HI.fate is derived from the HIV‑1 NL4‑3 molecular clone with defective env and vpr genes . E2‑Crimson is expressed from the HIV‑1 LTR and marks active viral gene expression (productively infected/replicating cells), whereas ZsGreen is expressed from an internal constitutive promoter and marks cells that have undergone HIV‑1 entry and proviral integration (all infected cells). In representative two‑parameter plots of E2‑Crimson versus ZsGreen fluorescence, quadrants were defined as follows: Q1 (double‑negative), uninfected cells; Q2 + Q3; E2‑Crimson⁺ with or without ZsGreen, productively infected cells; Q4; ZsGreen⁺ only, latently infected cells . HOS- CD4 + CXCR4 + and HOS-CD4 - CXCR4 + cells were infected with HXB2-pseudotyped HI.fate.E virus. Cells were acquired for flow cytometry analysis 72 hours post infection. Representative data from one of three independent biological experiments as shown. Panels B and C (top) show no‑virus controls used to define background fluorescence and gating thresholds. (B) In CD4 + CXCR4 + cells (bottom), 2.3% of cells were productively infected (P5) and 0.4% were latently infected. (C) In CD4 - CXCR4 + cells (bottom), 0.06% of cells were productively infected and 0.02% were latently infected. Data shown are presented as percentages of total live, single cells. was created using BioRender.com.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: (A) Schematic and gating strategy for the HI.fate dual‑fluorescent reporter system. HI.fate is derived from the HIV‑1 NL4‑3 molecular clone with defective env and vpr genes . E2‑Crimson is expressed from the HIV‑1 LTR and marks active viral gene expression (productively infected/replicating cells), whereas ZsGreen is expressed from an internal constitutive promoter and marks cells that have undergone HIV‑1 entry and proviral integration (all infected cells). In representative two‑parameter plots of E2‑Crimson versus ZsGreen fluorescence, quadrants were defined as follows: Q1 (double‑negative), uninfected cells; Q2 + Q3; E2‑Crimson⁺ with or without ZsGreen, productively infected cells; Q4; ZsGreen⁺ only, latently infected cells . HOS- CD4 + CXCR4 + and HOS-CD4 - CXCR4 + cells were infected with HXB2-pseudotyped HI.fate.E virus. Cells were acquired for flow cytometry analysis 72 hours post infection. Representative data from one of three independent biological experiments as shown. Panels B and C (top) show no‑virus controls used to define background fluorescence and gating thresholds. (B) In CD4 + CXCR4 + cells (bottom), 2.3% of cells were productively infected (P5) and 0.4% were latently infected. (C) In CD4 - CXCR4 + cells (bottom), 0.06% of cells were productively infected and 0.02% were latently infected. Data shown are presented as percentages of total live, single cells. was created using BioRender.com.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Derivative Assay, Gene Expression, Infection, Fluorescence, Virus, Flow Cytometry, Analysis